1384 related articles for article (PubMed ID: 14974925)
41. Salivary cortisol measurement--a reliable method for the diagnosis of Cushing's syndrome.
Trilck M; Flitsch J; Lüdecke DK; Jung R; Petersenn S
Exp Clin Endocrinol Diabetes; 2005 Apr; 113(4):225-30. PubMed ID: 15891959
[TBL] [Abstract][Full Text] [Related]
42. Gender-related differences in the presentation and course of Cushing's disease.
Pecori Giraldi F; Moro M; Cavagnini F;
J Clin Endocrinol Metab; 2003 Apr; 88(4):1554-8. PubMed ID: 12679438
[TBL] [Abstract][Full Text] [Related]
43. Diagnostic tests for children who are referred for the investigation of Cushing syndrome.
Batista DL; Riar J; Keil M; Stratakis CA
Pediatrics; 2007 Sep; 120(3):e575-86. PubMed ID: 17698579
[TBL] [Abstract][Full Text] [Related]
44. [Cushing's syndrome. I. New diagnostic developments].
van Aken MO; Feelders RA; de Jong FH; Pereira AM; Lamberts SW; de Herder WW
Ned Tijdschr Geneeskd; 2006 Oct; 150(43):2359-64. PubMed ID: 17100126
[TBL] [Abstract][Full Text] [Related]
45. Intermittent Cushing's disease in hirsute women.
Bals-Pratsch M; Hanker JP; Hellhammer DH; Lüdecke DK; Schlegel W; Schneider HP
Horm Metab Res; 1996 Feb; 28(2):105-10. PubMed ID: 8867908
[TBL] [Abstract][Full Text] [Related]
46. Comparison of efficacy between 1 mg overnight dexamethasone suppression test and 2-day low dose dexamethasone suppression test for diagnosis of Cushing's syndrome.
Kungpanichkul N
J Med Assoc Thai; 2010 Jan; 93(1):27-33. PubMed ID: 20196407
[TBL] [Abstract][Full Text] [Related]
47. A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome.
Newell-Price J; Perry L; Medbak S; Monson J; Savage M; Besser M; Grossman A
J Clin Endocrinol Metab; 1997 Jan; 82(1):176-81. PubMed ID: 8989255
[TBL] [Abstract][Full Text] [Related]
48. The corticotropin-releasing hormone test in the diagnosis of ACTH-dependent Cushing's syndrome: a reappraisal.
Pecori Giraldi F; Invitti C; Cavagnini F;
Clin Endocrinol (Oxf); 2001 May; 54(5):601-7. PubMed ID: 11380490
[TBL] [Abstract][Full Text] [Related]
49. Out-patient screening for Cushing's syndrome: the sensitivity of the combination of circadian rhythm and overnight dexamethasone suppression salivary cortisol tests.
Castro M; Elias PC; Quidute AR; Halah FP; Moreira AC
J Clin Endocrinol Metab; 1999 Mar; 84(3):878-82. PubMed ID: 10084565
[TBL] [Abstract][Full Text] [Related]
50. Salivary cortisol for screening of Cushing's syndrome in children.
Martinelli CE; Sader SL; Oliveira EB; Daneluzzi JC; Moreira AC
Clin Endocrinol (Oxf); 1999 Jul; 51(1):67-71. PubMed ID: 10468967
[TBL] [Abstract][Full Text] [Related]
51. Corticotropin-releasing factor (CRF) stimulation test in normal subjects and patients with Cushing's syndrome.
Zacharieva S; Matrosov P; Stoeva I; Kirilov G
Exp Clin Endocrinol; 1989 Apr; 93(1):19-28. PubMed ID: 2544435
[TBL] [Abstract][Full Text] [Related]
52. The limited value of the desmopressin test in the diagnostic approach to Cushing's syndrome.
Terzolo M; Reimondo G; Alì A; Borretta G; Cesario F; Pia A; Paccotti P; Angeli A
Clin Endocrinol (Oxf); 2001 May; 54(5):609-16. PubMed ID: 11380491
[TBL] [Abstract][Full Text] [Related]
53. The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome.
Findling JW; Raff H; Aron DC
J Clin Endocrinol Metab; 2004 Mar; 89(3):1222-6. PubMed ID: 15001614
[TBL] [Abstract][Full Text] [Related]
54. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications.
Gold PW; Loriaux DL; Roy A; Kling MA; Calabrese JR; Kellner CH; Nieman LK; Post RM; Pickar D; Gallucci W
N Engl J Med; 1986 May; 314(21):1329-35. PubMed ID: 3010108
[TBL] [Abstract][Full Text] [Related]
55. CRF in the differential diagnosis of Cushing's syndrome: a comparison with the dexamethasone suppression test.
Grossman AB; Howlett TA; Perry L; Coy DH; Savage MO; Lavender P; Rees LH; Besser GM
Clin Endocrinol (Oxf); 1988 Aug; 29(2):167-78. PubMed ID: 2854761
[TBL] [Abstract][Full Text] [Related]
56. Cavernous and inferior petrosal sinus sampling in the evaluation of ACTH-dependent Cushing's syndrome.
Liu C; Lo JC; Dowd CF; Wilson CB; Kunwar S; Aron DC; Tyrrell JB
Clin Endocrinol (Oxf); 2004 Oct; 61(4):478-86. PubMed ID: 15473881
[TBL] [Abstract][Full Text] [Related]
57. Dynamic pituitary MRI has high sensitivity and specificity for the diagnosis of mild Cushing's syndrome and should be part of the initial workup.
Friedman TC; Zuckerbraun E; Lee ML; Kabil MS; Shahinian H
Horm Metab Res; 2007 Jun; 39(6):451-6. PubMed ID: 17578763
[TBL] [Abstract][Full Text] [Related]
58. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
[TBL] [Abstract][Full Text] [Related]
59. Clinical features, diagnosis, treatment and molecular studies in paediatric Cushing's syndrome due to primary nodular adrenocortical hyperplasia.
Storr HL; Mitchell H; Swords FM; Main KM; Hindmarsh PC; Betts PR; Shaw NJ; Johnston DI; Clark AJ; Reznek RH; Grossman AB; Savage MO
Clin Endocrinol (Oxf); 2004 Nov; 61(5):553-9. PubMed ID: 15521956
[TBL] [Abstract][Full Text] [Related]
60. The ovine corticotropin-releasing hormone stimulation test and the dexamethasone suppression test in the differential diagnosis of Cushing's syndrome.
Nieman LK; Chrousos GP; Oldfield EH; Avgerinos PC; Cutler GB; Loriaux DL
Ann Intern Med; 1986 Dec; 105(6):862-7. PubMed ID: 3022629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
